Clinical Trial Update: Glucagon-like Peptide-1 in Type 1 Diabetes [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating a glucagon-like peptide-1 therapy for Type 1 diabetes mellitus was withdrawn, sponsored by the University of Maryland, Baltimo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• glucagon-like peptide-1 (glucagon-like peptide-1)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Type1 Diabetes Mellitus | EARLY_Phase 1 | Status: WITHDRAWN